
10x Genomics has acquired Proteintech Genomics, a company specializing in high-plex proteomic solutions compatible with 10x's single cell and spatial biology platforms. This acquisition expands 10x Genomics' capabilities in proteomics, enabling integrated analysis of proteins and RNA at the single cell level. The move supports 10x's vision for richer multiomic approaches to biological research, advancing studies in immunology, oncology, neuroscience, and more. The acquisition is expected to strengthen 10x's product offerings without significantly impacting its near-term financial outlook.